Bernd Hoppe

Summary

Affiliation: University of Cologne
Country: Germany

Publications

  1. ncbi Diagnostic and therapeutic strategies in hyperoxaluria: a plea for early intervention
    Bernd Hoppe
    University Children's Hospital, Division of Paediatric Nephrology, University of Cologne, Josef-Stelzmann Strasse 9, D-50931 Cologne, Germany
    Nephrol Dial Transplant 19:39-42. 2004
  2. ncbi Nephrocalcinosis in preterm infants: a single center experience
    Bernd Hoppe
    Pediatric Nephrology, University Children s Hospital, Josef Stelzmann Strasse 9, 50924 Cologne, Germany
    Pediatr Nephrol 17:264-8. 2002
  3. ncbi Hypocitraturia as a risk factor for nephrocalcinosis after kidney transplantation
    Ludwig Stapenhorst
    Division of Pediatric Nephrology, Department of Pediatrics, University Children s Hospital, 50924, Cologne, Germany
    Pediatr Nephrol 20:652-6. 2005
  4. ncbi Oxalate degrading bacteria: new treatment option for patients with primary and secondary hyperoxaluria?
    Bernd Hoppe
    University Children s Hospital Cologne, Division of Pediatric Nephrology, University of Cologne, Kerpenerstrasse 62, 50931 Cologne, Germany
    Urol Res 33:372-5. 2005
  5. ncbi A United States survey on diagnosis, treatment, and outcome of primary hyperoxaluria
    Bernd Hoppe
    Feinberg School of Medicine, Northwestern University, Chicago, Illinois, USA
    Pediatr Nephrol 18:986-91. 2003
  6. ncbi Diagnostic and therapeutic approaches in patients with secondary hyperoxaluria
    Bernd Hoppe
    University Children s Hospital, Pediatric Nephrology, D 50924 Cologne, Germany
    Front Biosci 8:e437-43. 2003
  7. ncbi Absorptive hyperoxaluria leads to an increased risk for urolithiasis or nephrocalcinosis in cystic fibrosis
    Bernd Hoppe
    University Children s Hospital Cologne, Germany, USA
    Am J Kidney Dis 46:440-5. 2005
  8. ncbi Reduction of plasma oxalate levels by oral application of Oxalobacter formigenes in 2 patients with infantile oxalosis
    Bernd Hoppe
    Department of Pediatric and Adolescent Medicine, Division of Pediatric Nephrology, University Hospital, Cologne, Germany
    Am J Kidney Dis 58:453-5. 2011
  9. ncbi Urinary NAG in children with urolithiasis, nephrocalcinosis, or risk of urolithiasis
    Przemyslaw Sikora
    Division of Pediatric Nephrology, University Children's Hospital, Josef-Stelzmann Strasse 9, 50924 Cologne, Germany
    Pediatr Nephrol 18:996-9. 2003
  10. ncbi Renal allograft calcification -- prevalence and etiology in pediatric patients
    Sandra Habbig
    Department of Pediatrics, Division of Pediatric Nephrology, University Hospital, Cologne, Germany
    Am J Nephrol 30:194-200. 2009

Detail Information

Publications37

  1. ncbi Diagnostic and therapeutic strategies in hyperoxaluria: a plea for early intervention
    Bernd Hoppe
    University Children's Hospital, Division of Paediatric Nephrology, University of Cologne, Josef-Stelzmann Strasse 9, D-50931 Cologne, Germany
    Nephrol Dial Transplant 19:39-42. 2004
  2. ncbi Nephrocalcinosis in preterm infants: a single center experience
    Bernd Hoppe
    Pediatric Nephrology, University Children s Hospital, Josef Stelzmann Strasse 9, 50924 Cologne, Germany
    Pediatr Nephrol 17:264-8. 2002
    ..The numbers have, however, increased over the past few years. From the follow-up it was obvious that long-term observation of preterm infants is necessary and that complications might arise in the long run...
  3. ncbi Hypocitraturia as a risk factor for nephrocalcinosis after kidney transplantation
    Ludwig Stapenhorst
    Division of Pediatric Nephrology, Department of Pediatrics, University Children s Hospital, 50924, Cologne, Germany
    Pediatr Nephrol 20:652-6. 2005
    ..Both findings can increase the risk for urolithiasis or nephrocalcinosis...
  4. ncbi Oxalate degrading bacteria: new treatment option for patients with primary and secondary hyperoxaluria?
    Bernd Hoppe
    University Children s Hospital Cologne, Division of Pediatric Nephrology, University of Cologne, Kerpenerstrasse 62, 50931 Cologne, Germany
    Urol Res 33:372-5. 2005
    ..O. formigenes might be a promising new therapeutic tool in patients with primary and secondary hyperoxaluria...
  5. ncbi A United States survey on diagnosis, treatment, and outcome of primary hyperoxaluria
    Bernd Hoppe
    Feinberg School of Medicine, Northwestern University, Chicago, Illinois, USA
    Pediatr Nephrol 18:986-91. 2003
    ..As isolated KTx failed in 59% of patients, combined liver-kidney Tx seems to be the better choice in place of isolated KTx as the primary transplant procedure...
  6. ncbi Diagnostic and therapeutic approaches in patients with secondary hyperoxaluria
    Bernd Hoppe
    University Children s Hospital, Pediatric Nephrology, D 50924 Cologne, Germany
    Front Biosci 8:e437-43. 2003
    ....
  7. ncbi Absorptive hyperoxaluria leads to an increased risk for urolithiasis or nephrocalcinosis in cystic fibrosis
    Bernd Hoppe
    University Children s Hospital Cologne, Germany, USA
    Am J Kidney Dis 46:440-5. 2005
    ..To better elucidate its pathophysiological characteristics, we prospectively studied patients with CF by determining these parameters and performing renal ultrasonography twice yearly...
  8. ncbi Reduction of plasma oxalate levels by oral application of Oxalobacter formigenes in 2 patients with infantile oxalosis
    Bernd Hoppe
    Department of Pediatric and Adolescent Medicine, Division of Pediatric Nephrology, University Hospital, Cologne, Germany
    Am J Kidney Dis 58:453-5. 2011
    ..Therefore, O formigenes therapy may be helpful as a bridging procedure until transplant in such patients...
  9. ncbi Urinary NAG in children with urolithiasis, nephrocalcinosis, or risk of urolithiasis
    Przemyslaw Sikora
    Division of Pediatric Nephrology, University Children's Hospital, Josef-Stelzmann Strasse 9, 50924 Cologne, Germany
    Pediatr Nephrol 18:996-9. 2003
    ..The mechanism of cell damage in these conditions however, seems to be complex. Neither HyOx nor HC alone were sufficient to induce severe tubular damage expressed as an increase in NAG excretion in our patients...
  10. ncbi Renal allograft calcification -- prevalence and etiology in pediatric patients
    Sandra Habbig
    Department of Pediatrics, Division of Pediatric Nephrology, University Hospital, Cologne, Germany
    Am J Nephrol 30:194-200. 2009
    ..Persistent hyperparathyroidism, hypercalcemia and concomitant hypercalciuria were identified as major risk factors. We aimed to determine the prevalence and risk factors for such calcifications in children...
  11. ncbi Hypocitraturia is one of the major risk factors for nephrocalcinosis in very low birth weight (VLBW) infants
    Przemyslaw Sikora
    Division of Pediatric Nephrology, University Children's Hospital Cologne, Cologne, Germany
    Kidney Int 63:2194-9. 2003
    ..The urinary excretions in VLBW infants seem to depend on birth weight, age, and clinical condition. Hence, supplementation with alkali citrate may have a beneficial effect in the prevention of NC...
  12. ncbi Primary hyperoxaluria--the German experience
    Bernd Hoppe
    Division of Pediatric Nephrology, Children s Hospital Cologne, University of Cologne, Cologne, Germany
    Am J Nephrol 25:276-81. 2005
    ..Primary hyperoxaluria (PH) is a heterogeneous disease with variable age of onset and inconsistent progression into renal failure (ESRF)...
  13. ncbi Detection of polyomavirus BK and JC in children with kidney diseases and renal transplant recipients
    Andreas Muller
    Department of Pediatrics, University of Bonn, Bonn, Germany
    Pediatr Infect Dis J 24:778-81. 2005
    ..Testing for polyomavirus DNA in plasma has been described as a sensitive and specific method to discover viral nephropathy in adult patients. We were now interested in polyomavirus status in a pediatric patient setting...
  14. ncbi The primary hyperoxalurias
    Bernd Hoppe
    Division of Pediatric Nephrology, Department of Pediatrics, University Hospital, Cologne, Germany
    Kidney Int 75:1264-71. 2009
    ..Promising areas of investigation are being identified. Knowledge of the spectrum of disease expression, early diagnosis, and initiation of treatment before renal failure are essential to realize a benefit for patients...
  15. ncbi Nephrocalcinosis and urolithiasis in children
    Sandra Habbig
    Division of Pediatric Nephrology, Department of Pediatrics, University of Cologne, Cologne, Germany
    Kidney Int 80:1278-91. 2011
    ....
  16. ncbi Evidence of true genotype-phenotype correlation in primary hyperoxaluria type 1
    Bernd Hoppe
    Division of Pediatric Nephrology, Department of Pediatrics, University Hospital Cologne, Cologne, Germany
    Kidney Int 77:383-5. 2010
    ..Harambat and co-workers report on this situation, presenting data on a major population of genotyped patients...
  17. ncbi Transplantation procedures in children with primary hyperoxaluria type 1: outcome and longitudinal growth
    Florian Brinkert
    Department of Pediatrics, Pediatric Gastroenterology and Hepatology, University Medical Centre Hamburg Eppendorf, Hamburg, Germany
    Transplantation 87:1415-21. 2009
    ..Sometimes a sequential approach for LKTx (first liver, then kidney) has been recommended...
  18. ncbi Hyperoxaluria after ethylene glycol poisoning
    Ludwig Stapenhorst
    Department of Pediatrics, University Children s Hospital, 50924, Cologne, Germany
    Pediatr Nephrol 23:2277-9. 2008
    ..Metabolic acidosis, hypocalcaemia, and neurological symptoms had not occurred. Four weeks after discharge, both plasma and urinary oxalate levels were normal...
  19. ncbi The case: A boy with recurrent stones
    Bodo B Beck
    Division of Pediatric Nephrology, Department of Pediatrics, University Hospital Cologne, Cologne, Germany
    Kidney Int 74:133-4. 2008
  20. ncbi Successful plasma therapy for atypical hemolytic uremic syndrome caused by factor H deficiency owing to a novel mutation in the complement cofactor protein domain 15
    Christoph Licht
    Division of Pediatric Nephrology, Children's Hospital of the University of Cologne, Cologne, Germany
    Am J Kidney Dis 45:415-21. 2005
    ..Based on the measured factor H half-life of about 6 days, regular plasma infusions in 2-week intervals were given, which prevented further aHUS episodes and stopped the decline of kidney function...
  21. ncbi Community-acquired pneumonia due to Bordetella holmesii in a patient with frequently relapsing nephrotic syndrome
    Christina Dörbecker
    Institute for Medical Microbiology, Immunology and Hygiene, University of Cologne, Goldenfelsstr 19 21, 50935 Cologne, Germany
    J Infect 54:e203-5. 2007
    ..Herein, we describe a patient with severe relapse of nephrotic syndrome associated with bacteremic B. holmesii pneumonia...
  22. ncbi Diagnostic examination of the child with urolithiasis or nephrocalcinosis
    Bernd Hoppe
    Department of Pediatrics, Division of Pediatric Nephrology, University Children s Hospital Cologne, Kerpenerstr 62, 50924, Cologne, Germany
    Pediatr Nephrol 25:403-13. 2010
    ..The stone is not the disease itself; it is only one serious sign! Therefore, thorough and early diagnostic examination is mandatory for every infant and child with the first stone event, or with nephrocalcinosis...
  23. ncbi Mutation analysis of the Uromodulin gene in 96 individuals with urinary tract anomalies (CAKUT)
    Matthias T F Wolf
    Department of Pediatrics, University of Michigan, Ann Arbor, MI, USA
    Pediatr Nephrol 24:55-60. 2009
    ..Six previously known and seven new single nucleotide polymorphisms (SNPs) were detected. As no UMOD mutations were identified in these 96 patients with CAKUT, UMOD mutations do not seem to be a significant cause of CAKUT in this cohort...
  24. ncbi Uromodulin is expressed in renal primary cilia and UMOD mutations result in decreased ciliary uromodulin expression
    Frank Zaucke
    Center for Biochemistry, Medical Faculty, University Children s Hospital, University of Cologne, Cologne, Germany
    Hum Mol Genet 19:1985-97. 2010
    ..Our data add UMOD to the group of proteins expressed in primary cilia, where mutations of the gene lead to cystic kidney disease...
  25. ncbi Mutation analysis of 18 nephronophthisis associated ciliopathy disease genes using a DNA pooling and next generation sequencing strategy
    Edgar A Otto
    Department of Pediatrics, University of Michigan, Ann Arbor, Michigan, USA
    J Med Genet 48:105-16. 2011
    ..To overcome the broad genetic locus heterogeneity, a strategy of DNA pooling with consecutive massively parallel resequencing (MPR) was devised...
  26. ncbi Respiratory and general outcome in neonates with renal oligohydramnios--a single-centre experience
    Katrin Mehler
    Division of Neonatology and Paediatric Intensive Care Medicine, Children s Hospital, University of Cologne, Cologne, Germany
    Nephrol Dial Transplant 26:3514-22. 2011
    ....
  27. ncbi Mutations in the Wilms' tumor 1 gene cause isolated steroid resistant nephrotic syndrome and occur in exons 8 and 9
    Bettina Mucha
    Department of Pediatrics, University of Michigan, Ann Arbor, 48109, USA
    Pediatr Res 59:325-31. 2006
    ..Kidney Int 66: 564-570, 2004) indicate that screening of WT1 exons 8 and 9 in patients with sporadic SRNS is sufficient to detect pathogenic WT1 mutations and may open inroads into differential therapy of SRNS...
  28. ncbi Cardiorespiratory capacity in children and adolescents on maintenance haemodialysis
    Bettina Schaar
    Institute of Health Promotion and Clinical Movement Science, German Sport University Cologne, Cologne, Germany
    Nephrol Dial Transplant 26:3701-8. 2011
    ..However, physical endurance was up to now only examined on non-HD days. We were interested in the effect of HD on the cardiorespiratory capacity of children and adolescents on maintenance HD...
  29. ncbi Two novel ADAMTS13 gene mutations in thrombotic thrombocytopenic purpura/hemolytic-uremic syndrome (TTP/HUS)
    Christoph Licht
    Department of Pediatric Nephrology and Pediatric Hematology Oncology, University Children s Hospital of Cologne, Cologne, Germany
    Kidney Int 66:955-8. 2004
    ..One possible reason is the deficiency of von Willebrand factor-cleaving protease (vWF-CP) resulting in persistence of uncleaved, ultralarge von Willebrand factor multimers (ULvWFM)...
  30. ncbi Efficacy and safety of Oxalobacter formigenes to reduce urinary oxalate in primary hyperoxaluria
    Bernd Hoppe
    Division of Paediatric Nephrology, Department of Paediatric and Adolescent Medicine, University Hospital Cologne, Cologne, Germany
    Nephrol Dial Transplant 26:3609-15. 2011
    ..Orally administered O. formigenes (Oxabact) was found to significantly reduce urine and plasma oxalate. We aimed to evaluate its effect and safety in a randomized, double-blind, placebo-controlled multicenter study...
  31. ncbi Posttransplant lymphoproliferative disease in a child: clinical and molecular characterization
    Christoph Licht
    Children s Hospital, The University of Cologne, Cologne, Germany
    Pediatr Nephrol 17:79-84. 2002
    ..EBV-PCR in plasma was negative (0.02 x 10(6) copies/ml blood) 12 weeks after reduction of immunosuppression. The liver masses completely resolved after 27 months. After a total follow-up of 36 months the child remains in good health...
  32. ncbi Atypical presentation of distal renal tubular acidosis in two siblings
    Velibor Tasic
    Department of Pediatric Nephrology, Children s Hospital, 17 Vodnjanska, Skopje, Macedonia
    Pediatr Nephrol 23:1177-81. 2008
    ..In conclusion, proximal tubular dysfunction and hyperoxaluria may be found in children with dRTA and are reversible under appropriate therapy...
  33. ncbi A cutaneous disease with multisystem involvement: hypomelanosis of Ito may be associated with proteinuria, focal segmental glomerulosclerosis and end-stage renal disease
    Nina Gatter
    Nephrol Dial Transplant 22:1796-8. 2007
  34. ncbi Primary hyperoxaluria type 1: is genotyping clinically helpful?
    Ernst Leumann
    Pediatr Nephrol 20:555-7. 2005
    ..Pyridoxine responsiveness can be anticipated in some genotypes (508G>A (Gly170Arg) and 454T>A (Phe153Ile)), but it should still be tested for in all patients. Genetic testing is thus clinically helpful but has clear limitations...
  35. ncbi Determination of the calcium oxalate crystallization risk from urine samples: the BONN Risk Index in comparison to other risk formulas
    Norbert Laube
    Division of Experimental Urology, Department of Urology, University of Bonn, Bonn, Germany
    J Urol 172:355-9. 2004
    ....
  36. ncbi Genetic analysis: a diagnostic tool for primary hyperoxaluria type 1
    Christian von Schnakenburg
    Pediatr Nephrol 18:482-3; author reply 484. 2003
  37. ncbi MPGN II--genetically determined by defective complement regulation?
    Christoph Licht
    Pediatr Nephrol 22:2-9. 2007
    ..Identification of patients with MPGN II caused by defective complement control may allow treatment by replacement of the missing factor via plasma infusion, thus possibly preventing or at least delaying disease progress...